BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, December 5, 2025
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 1, 2010
View Archived Issues
Preclinical activity of LY-S6KAKT1 justifies entry into phase I trial as cancer therapy
Read More
GlaxoSmithKline claims new inhibitors of focal adhesion kinase 1
Read More
High Point Pharma patents new beta-secretase 1 inhibitors
Read More
Roche describes novel inverse agonists of GABA(A) receptor
Read More
Multikinase inhibitor AI-1008 shows promise to treat chronic myeloid leukemia in preclinical testing
Read More
Phase I data presented on MEDI-573 and MEDI-575 in advanced solid tumors
Read More
Pfizer's AadAT inhibitor PF-4859989 shows activity in vivo
Read More
Atrasentan reduces albuminuria in patients with diabetes-associated nephropathy
Read More
Elan presents new antagonists of integrin alpha-4/beta-7
Read More
FDA clears design of phase III oritavancin trials SOLO-1 and -2
Read More
UCB updates progress from third quarter of 2010
Read More
Ohio State University claims new inhibitors of prostaglandin G/H synthase 2
Read More
Immunovaccine and OncoTherapy Science join to develop cancer vaccine
Read More
Renhuang Pharmaceuticals changes name to China Botanic Pharmaceutical
Read More
Optimer Pharma submits NDA for fidaxomicin to FDA and requests priority review
Read More
Pfizer's phase III axitinib trial in renal cell carcinoma meets primary endpoint
Read More
Tamir Biotechnology compounds show encouraging in vitro activity against HPV
Read More
Transition Therapeutics and Elan amend agreement on scyllo-inositol
Read More
Anacor, UCSF and LFKRI team up to discover onchocerciasis therapies
Read More
ACT files IND for phase I/II trial of MA-09-HRPE in dry AMD
Read More
NanoBio receives grant to develop vaccine against RSV infection
Read More
Savient Pharma's Krystexxa is available by prescription in U.S.
Read More
Ikaria begins pivotal phase III Lucassin trial in hepatorenal syndrome type 1
Read More
Accentia forms strategic alliance with Baxter
Read More
CBLB-502 receives FDA orphan drug status for prevention of death following irradiation
Read More